Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 298

1.

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.

Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I.

Oncotarget. 2014 Jun 19. [Epub ahead of print]

PMID:
25015789
[PubMed - as supplied by publisher]
Free Article
2.

Comparison of 68Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.

Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, Roethke MC, Schlemmer HP, Haberkorn U.

Neuro Oncol. 2014 Jul 9. pii: nou131. [Epub ahead of print]

PMID:
25008094
[PubMed - as supplied by publisher]
3.

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K.

Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.

PMID:
24983957
[PubMed]
Free Article
4.

Current status in the therapy of liver diseases.

Uhl P, Fricker G, Haberkorn U, Mier W.

Int J Mol Sci. 2014 Apr 30;15(5):7500-12. doi: 10.3390/ijms15057500.

PMID:
24786290
[PubMed - in process]
Free PMC Article
5.

Noninvasive risk stratification of patients with transthyretin amyloidosis.

Kristen AV, Scherer K, Buss S, aus dem Siepen F, Haufe S, Bauer R, Hinderhofer K, Giannitsis E, Hardt S, Haberkorn U, Katus HA, Steen H.

JACC Cardiovasc Imaging. 2014 May;7(5):502-10. doi: 10.1016/j.jcmg.2014.03.002. Epub 2014 Apr 9.

PMID:
24726252
[PubMed - in process]
6.

Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.

Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blöcker IM, Bahtz R, Komorowski L, Stöcker W, Kastrup A, Kuthe M, Meinck HM.

Neurology. 2014 Apr 29;82(17):1521-8. doi: 10.1212/WNL.0000000000000372. Epub 2014 Apr 2.

PMID:
24696508
[PubMed - indexed for MEDLINE]
7.

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.

Zechmann CM, Afshar-Oromieh A, Armor T, Stubbs JB, Mier W, Hadaschik B, Joyal J, Kopka K, Debus J, Babich JW, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1280-92. doi: 10.1007/s00259-014-2713-y. Epub 2014 Feb 28.

PMID:
24577951
[PubMed - in process]
Free PMC Article
8.

A disulfide-constrained miniprotein with striking tumor-binding specificity developed by ribosome display.

Zoller F, Markert A, Barthe P, Hebling U, Altmann A, Lindner T, Mier W, Haberkorn U.

Angew Chem Int Ed Engl. 2013 Nov 4;52(45):11760-4. doi: 10.1002/anie.201304603. Epub 2013 Sep 20. No abstract available.

PMID:
24573723
[PubMed - in process]
9.

PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.

Sachpekidis C, Goldschmidt H, Hose D, Pan L, Cheng C, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1343-53. doi: 10.1007/s00259-014-2721-y. Epub 2014 Feb 22.

PMID:
24562650
[PubMed - in process]
10.

Radiolabeling strategies for tumor-targeting proteinaceous drugs.

Sugiura G, Kühn H, Sauter M, Haberkorn U, Mier W.

Molecules. 2014 Feb 18;19(2):2135-65. doi: 10.3390/molecules19022135.

PMID:
24552984
[PubMed - in process]
Free Article
11.

Multimodal Imaging for Early Functional Response Assessment of (90)Y-/ (177)Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.

Wulfert S, Kratochwil C, Choyke PL, Afshar-Oromieh A, Mier W, Kauczor HU, Schenk JP, Haberkorn U, Giesel FL.

Mol Imaging Biol. 2014 Aug;16(4):586-94. doi: 10.1007/s11307-014-0722-7.

PMID:
24526358
[PubMed - in process]
12.

Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.

Flechsig P, Kratochwil C, Schwartz LH, Rath D, Moltz J, Antoch G, Heussel CP, Rieser M, Warth A, Zabeck H, Kauczor HU, Haberkorn U, Giesel FL.

J Nucl Med. 2014 Apr;55(4):559-64. doi: 10.2967/jnumed.113.128504. Epub 2014 Feb 13.

PMID:
24525209
[PubMed - indexed for MEDLINE]
13.

Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.

Eder M, Schäfer M, Bauder-Wüst U, Haberkorn U, Eisenhut M, Kopka K.

Prostate. 2014 May;74(6):659-68. doi: 10.1002/pros.22784. Epub 2014 Jan 25.

PMID:
24464532
[PubMed - indexed for MEDLINE]
14.

Screening of a novel peptide targeting the proteoglycan-like region of human carbonic anhydrase IX.

Rana S, Nissen F, Lindner T, Altmann A, Mier W, Debus J, Haberkorn U, Askoxylakis V.

Mol Imaging. 2013 Nov-Dec;12(8). doi: 10.2310/7290.2013.00066.

PMID:
24447616
[PubMed - in process]
15.

[Importance of nuclear medicine diagnostics in CUP syndrome].

Winter MC, Haberkorn U, Kratochwil C.

Radiologe. 2014 Feb;54(2):134-9. doi: 10.1007/s00117-013-2548-8. German.

PMID:
24445408
[PubMed - in process]
16.

Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy.

Kratochwil C, Mavriopoulou E, Rath D, Afshar-Oromieh A, Apostolopoulos D, Haufe S, Mier W, Haberkorn U, Giesel FL.

Q J Nucl Med Mol Imaging. 2014 Jan 2. [Epub ahead of print]

PMID:
24382404
[PubMed - as supplied by publisher]
17.

Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, Hadaschik BA, Kopp-Schneider A, Röthke M.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.

PMID:
24352789
[PubMed - in process]
18.

Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.

Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, Haberkorn U, Giesel FL.

Neuro Oncol. 2014 Mar;16(3):434-40. doi: 10.1093/neuonc/not199. Epub 2013 Dec 4.

PMID:
24305717
[PubMed - in process]
19.

Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.

Mier W, Kratochwil C, Hassel JC, Giesel FL, Beijer B, Babich JW, Friebe M, Eisenhut M, Enk A, Haberkorn U.

J Nucl Med. 2014 Jan;55(1):9-14. doi: 10.2967/jnumed.112.112789. Epub 2013 Nov 25.

PMID:
24277756
[PubMed - indexed for MEDLINE]
20.

Is nano too big?

Mier W, Babich J, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):4-6. doi: 10.1007/s00259-013-2574-9. No abstract available.

PMID:
24092264
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk